Florian Stöckigt

Florian Stöckigt

Auto-generated profile, based on publicly available information

Florian Stöckigt

Department of Cardiology, Electrophysiology and Rhythmology Krankenhaus Porz Am Rhein Cologne Germany

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
RSRobert Schueler
Robert Schueler
CÖCan Öztürk
Can Öztürk
JWJan Arne Wedekind
Jan Arne Wedekind
NWNikos Werner
Nikos Werner
FSFlorian Stöckigt
Florian Stöckigt
CHChristoph Hammerstingl
Christoph Hammerstingl

1 May 2015 in Cell Metabolism
Verified
Journal Article
Closed access
OBOlivier R. Baris
Olivier R. Baris
SEStefan Ederer
Stefan Ederer
JNJohannes F.G. Neuhaus
Johannes F.G. Neuhaus
JKJürgen-Christoph von Kleist-Retzow
Jürgen-Christoph von Kleist-Retzow
CWClaudia M. Wunderlich
Claudia M. Wunderlich
RWRudolf J. Wiesner
Rudolf J. Wiesner

9 April 2012 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
FSFlorian Stöckigt
Florian Stöckigt
JSJan W. Schrickel
Jan W. Schrickel
RARené Andrié
René Andrié
LLLars Lickfett
Lars Lickfett

14 November 2014 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
CCChristoph S. Clemen
Christoph S. Clemen
FSFlorian Stöckigt
Florian Stöckigt
KSKarl-Heinz Strucksberg
Karl-Heinz Strucksberg
FCFrederic Chevessier
Frederic Chevessier
LWLilli Winter
Lilli Winter
RSRolf Schröder
Rolf Schröder
Mutations of the human desmin gene on chromosome 2q35 cause autosomal dominant, autosomal recessive and sporadic forms of protein aggregation myopathies and cardiomyopathies. We generated R349P desmin knock-in mice, which harbor the ortholog of the most frequently occurring human desmin missense mutation R350P. These mice develop age-dependent desmin-positive protein aggregation pathology, skeletal muscle weakness, dilated cardiomyopathy, as well as cardiac arrhythmias and conduction defects. For the first time, we report the expression level and subcellular distribution of mutant versus wild-type desmin in our mouse model as well as in skeletal muscle specimens derived from human R350P desminopathies. Furthermore, we demonstrate that the missense-mutant desmin inflicts changes of the subcellular localization and turnover of desmin itself and of direct desmin-binding partners. Our findings unveil a novel principle of pathogenesis, in which not the presence of protein aggregates, but disruption of the extrasarcomeric intermediate filament network leads to increased mechanical vulnerability of muscle fibers. These structural defects elicited at the myofiber level finally impact the entire organ and subsequently cause myopathy and cardiomyopathy.

4 September 2012 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
VPVivek S. Peche
Vivek S. Peche
THTad A. Holak
Tad A. Holak
BBBhagyashri D. Burgute
Bhagyashri D. Burgute
KKKosmas Kosmas
Kosmas Kosmas
SKSushant P. Kale
Sushant P. Kale
ANAngelika A. Noegel
Angelika A. Noegel

18 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KFKai Friedrichs
Kai Friedrichs
MAMatti Adam
Matti Adam
LRLisa Remane
Lisa Remane
MMMartin Mollenhauer
Martin Mollenhauer
VRVolker Rudolph
Volker Rudolph
AKAnna Klinke
Anna Klinke
Recent observational clinical and ex-vivo studies suggest that inflammation and in particular leukocyte activation predisposes to atrial fibrillation (AF). However, whether local binding and extravasation of leukocytes into atrial myocardium is an essential prerequisite for the initiation and propagation of AF remains elusive. Here we investigated the role of atrial CD11b/CD18 mediated infiltration of polymorphonuclear neutrophils (PMN) for the susceptibility to AF. C57bl/6J wildtype (WT) and CD11b/CD18 knock-out (CD11b−/−) mice were treated for 14 days with subcutaneous infusion of angiotensin II (Ang II), a known stimulus for PMN activation. Atria of Ang II-treated WT mice were characterized by increased PMN infiltration assessed in immunohistochemically stained sections. In contrast, atrial sections of CD11b−/− mice lacked a significant increase in PMN infiltration upon Ang II infusion. PMN infiltration was accompanied by profoundly enhanced atrial fibrosis in Ang II treated WT as compared to CD11b−/− mice. Upon in-vivo electrophysiological investigation, Ang II treatment significantly elevated the susceptibility for AF in WT mice if compared to vehicle treated animals given an increased number and increased duration of AF episodes. In contrast, animals deficient of CD11b/CD18 were entirely protected from AF induction. Likewise, epicardial activation mapping revealed decreased electrical conduction velocity in atria of Ang II treated WT mice, which was preserved in CD11b−/− mice. In addition, atrial PMN infiltration was enhanced in atrial appendage sections of patients with persistent AF as compared to patients without AF. The current data critically link CD11b-integrin mediated atrial PMN infiltration to the formation of fibrosis, which promotes the initiation and propagation of AF. These findings not only reveal a mechanistic role of leukocytes in AF but also point towards a potential novel avenue of treatment in AF.